Acknowledgement to Referees
A. E. Ades,Colin Angus,Rodrigo Antonini Ribeiro,Miqdad Brazil,Arthur Asaria,Netherlands Azman,Eduard J. Beck,Johannes Berkhof,Marcel The Netherlands,Christine Singapore,Johannes Germany,The Bogaards,Judith Netherlands,Netherlands Broder,James Buchanan,Thomas Butt,Michele Cecchini,James D. Chambers,H. S. Chen,Yingyao Chen,China Connolly,David Coultas,Simon Coulton,Karin S. Coyne,William H. Crown,Helen Dakin,Richard De,Abreu Lourenco,François Dionne,Joseph Canada,Alejandra Drozda,France Duenas,Brigitte Dunlap,Stig The Netherlands,Steven Evensen,Katherine A. Feldman
DOI: https://doi.org/10.1007/s40273-016-0469-x
2016-01-01
PharmacoEconomics
Abstract:As we approach the end of 2016, and publish our final issue of PharmacoEconomics for the year, we wish to reflect on another successful year for the journal and for others in the Adis Premier journals portfolio, and to thank all who have contributed to PharmacoEconomics over the past 12 months.Mid-2016 saw the release of the ISI Journal Citation Reports and the latest journal impact factors.PharmacoEconomics rose to 2.57.The majority of our other journals saw a rise in impact factor against the previous year.Most notably, five of our journals saw an increase of over 10% in impact factor-The Patient (17.08%),Clinical Drug Investigation (15.99%), the American Journal of Clinical Dermatology (13.17% increase), Drug Safety (13.52%), and Drugs (12.43%).Another important milestone was reached for our recently launched open access journals, Drug Safety-Case Reports and Drugs-Real World Outcomes.Content from these journals is now available on PubMed Central.The Adis journals portfolio will expand in 2017, with the launch of our sister journal PharmacoEconomics-Open.This new journal will be fully open access and will focus on the publication of applied research on the economic implications and health outcomes associated with drugs, devices and other healthcare interventions.It joins our other well respected health outcomes publications Applied Health Economics and Health Policy, and The Patient: Patient-Centered Outcomes Research.We offer our sincere thanks to all authors who have contributed articles to PharmacoEconomics over the course of 2016.Their skill and dedication are critical to the continued publication of the journal.The quality of published articles is, similarly, testament to the significant efforts of the peer reviewers, whose commitment ensures that the journal's content is held to the highest possible standard.